Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1-NKG2A Inhibitory Pathway

Immunity

Volumn 26, Issue 5, 2007, Pages 593-604

  Lu, Linrong ^a,b   Ikizawa, Koichi ^a   Hu, Dan ^a   Werneck, Miriam B F ^a,b   Wucherpfennig, Kai W ^a,b   Cantor, Harvey ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CELLIMMUNO; HUMDISEASE

Indexed keywords

BLOCKING ANTIBODY; CD94 ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A; T LYMPHOCYTE ANTIGEN;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING CELL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CELL MATURATION; CONTROLLED STUDY; CYTOLYSIS; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD94; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHIMERIN PROTEINS; DNA-BINDING PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; KILLER CELLS, NATURAL; LENTIVIRUS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 34248589088     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.03.017     Document Type: Article

References (41)

1. Aldrich C.J., Waltrip R., Hermel E., Attaya M., Lindahl K.F., Monaco J.J., and Forman J. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. J. Immunol. 149 (1992) 3773-3777
2. Bach J.F. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease. C. R. Biol. 329 (2006) 260-262
3. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197 (2003) 1073-1081
4. Brooks C.R., Elliott T., Parham P., and Khakoo S.I. The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells. J. Immunol. 176 (2006) 1141-1147
5. Chatenoud L. Anti-CD3 antibodies: towards clinical antigen-specific immunomodulation. Curr. Opin. Pharmacol. 4 (2004) 403-407
6. Durelli L., Bongioanni M.R., Cavallo R., Ferrero B., Ferri R., Verdun E., Bradac G.B., Riva A., Geuna M., and Bergamini L. Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function. Mult. Scler. 1 Suppl 1 (1995) S32-S37
7. Edwards B.S., Merritt J.A., Fuhlbrigge R.C., and Borden E.C. Low doses of interferon alpha result in more effective clinical natural killer cell activation. J. Clin. Invest. 75 (1985) 1908-1913
8. Gasser S., Orsulic S., Brown E.J., and Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005) 1186-1190
9. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., and Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195 (2002) 327-333
10. Hu D., Ikizawa K., Lu L., Sanchirico M.E., Shinohara M.L., and Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5 (2004) 516-523
11. Jacobs L.D., Beck R.W., Simon J.H., Kinkel R.P., Brownscheidle C.M., Murray T.J., Simonian N.A., Slasor P.J., and Sandrock A.W. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N. Engl. J. Med. 343 (2000) 898-904
12. Jiang H., Zhang S.-L., and Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256 (1992) 1213-1215
13. Karlhofer F.M., Ribaudo R.K., and Yokoyama W.M. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358 (1992) 66-70
14. b peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J. Exp. Med. 192 (2000) 613-623
15. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., and Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95 (1998) 5199-5204
16. Litwin V., Gumperz J., Parham P., Phillips J.H., and Lanier L.L. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180 (1994) 537-543
17. Lo W.F., Ong H., Metcalf E.S., and Soloski M.J. T cell responses to gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162 (1999) 5398-5406
18. Lo W.F., Woods A.S., DeCloux A., Cotter R.J., Metcalf E.S., and Soloski M.J. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat. Med. 6 (2000) 215-218
19. Lu L., Werneck M.B., and Cantor H. The immunoregulatory effects of Qa-1. Immunol. Rev. 212 (2006) 51-59
20. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., and Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5 (2004) 1260-1265
21. Mehrotra P.T., Donnelly R.P., Wong S., Kanegane H., Geremew A., Mostowski H.S., Furuke K., Siegel J.P., and Bloom E.T. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol. 160 (1998) 2637-2644
22. Moser J.M., Gibbs J., Jensen P.E., and Lukacher A.E. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat. Immunol. 3 (2002) 189-195
23. Ota T., Takeda K., Akiba H., Hayakawa Y., Ogasawara K., Ikarashi Y., Miyake S., Wakasugi H., Yamamura T., Kronenberg M., et al. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood 106 (2005) 184-192
24. Paust S., and Cantor H. Regulatory T cells and autoimmune disease. Immunol. Rev. 204 (2005) 195-207
25. Piccioli D., Sbrana S., Melandri E., and Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195 (2002) 335-341
26. Rabinovich B.A., Li J., Shannon J., Hurren R., Chalupny J., Cosman D., and Miller R.G. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170 (2003) 3572-3576
27. Raulet D.H. Missing self recognition and self tolerance of natural killer (NK) cells. Semin. Immunol. 18 (2006) 145-150
28. Raulet D.H., and Vance R.E. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6 (2006) 520-531
29. Schott E., Bonasio R., and Ploegh H.L. Elimination in vivo of developing T cells by natural killer cells. J. Exp. Med. 198 (2003) 1213-1224
30. Soloski M.J., DeCloux A., Aldrich C.J., and Forman J. Structural and functional characteristics of the class IB molecule, Qa-1. Immunol. Rev. 147 (1995) 67-89
31. Steinman L., and Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60 (2006) 12-21
32. Sullivan B.A., Kraj P., Weber D.A., Ignatowicz L., and Jensen P.E. Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. Immunity 17 (2002) 95-105
33. Suntharalingam G., Perry M.R., Ward S., Brett S.J., Castello-Cortes A., Brunner M.D., and Panoskaltsis N. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355 (2006) 1018-1028
34. Transy C., Nash S.R., David-Watine B., Cochet M., Hunt S.W., Hood L.E., and Kourilsky P. A low polymorphic mouse H-2 class I gene from the Tla complex is expressed in a broad variety of cell types. J. Exp. Med. 166 (1987) 341-361
35. b. J. Exp. Med. 188 (1998) 1841-1847
36. Wada H., Matsumoto N., Maenaka K., Suzuki K., and Yamamoto K. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur. J. Immunol. 34 (2004) 81-90
37. Wang M., Ellison C.A., Gartner J.G., and HayGlass K.T. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses. J. Immunol. 160 (1998) 1098-1105
38. Wang J., Sun R., Wei H., Dong Z., Gao B., and Tian Z. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. J. Hepatol. 44 (2006) 446-454
39. Willenborg D.O., Fordham S., Bernard C.C.A., Cowden W., and Ramshaw I.A. IFN-gamma plays a critical downregulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157 (1996) 3223-3227
40. Xu W., Fazekas G., Hara H., and Tabira T. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 163 (2005) 24-30
41. Zhang B., Yamamura T., Kondo T., Fujiwara M., and Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186 (1997) 1677-1687